Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05764707 · ClinicalTrials.gov registry record · Phase 2

Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Treatment in Spinal Surgery

A Phase 2 study, sponsored by Massachusetts General Hospital.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target

NCT05764707: Completed Phase 2 study, sponsored by Massachusetts General Hospital.

NCT05764707 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05764707, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target

Study Summary

Spinal surgeries are generally associated with intense pain in the postoperative period, especially for the initial few days. The aim of this study is to examine the effect of intraoperative intravenous acetaminophen in spine surgery on postoperative analgesic requirements, pain scores, patient satisfaction, and clinical recovery. Enrolled patients are randomized to receive either intravenous acetaminophen or placebo at the time of surgical closure. It is hypothesized that patients receiving intravenous acetaminophen will have improved pain scores, require less opiate medication, and have better patient satisfaction than those receiving placebo.

Interventions

  • DRUG Placebo
  • DRUG Acetaminophen

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-01-10
Est. Completion 2023-02-03
Phase Phase 2

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05764707

The ClinicalTrials.gov registry entry for NCT05764707 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT05764707 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05764707 about?

NCT05764707 is a clinical study titled "Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Treatment in Spinal Surgery". Spinal surgeries are generally associated with intense pain in the postoperative period, especially for the initial few days. The aim of this study is to examine the effect of intraoperative intravenous acetaminophen in spine surgery on postoperative analgesic requirements, pain scores, patient sati...

What is the current status of trial NCT05764707?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2020-01-10. Estimated completion is 2023-02-03.

What interventions are being tested in trial NCT05764707?

The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT05764707?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.